TGFBR1 and liver cancer: With pbMOO approach, a new pathway “TGFβ1- TGFβR1- AR-OCIAD2” in liver cancer mesenchymal stem cell was predicted, which will differentiate into Tumor-Associated-Fibroblasts (TAFs), one of the major components of tumor stroma.